Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMVWYOU)

Drug Name
GGF Drug Info
Indication
Disease Entry ICD 11 Status REF
Congestive heart failure BD10 Phase 1b [1]
Cross-matching ID
PubChem CID
136239306
TTD Drug ID
DMVWYOU

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Pro-neuregulin-1 (Pro-NRG1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Neucardin DME617W Heart failure BD10-BD13 Phase 3 [3]
GGF-2 DMDMPKC Heart failure BD10-BD13 Phase 1 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Pro-neuregulin-1 (Pro-NRG1) TTEH395 NRG1_HUMAN Modulator [2]

References

1 Clinical pipeline report, company report or official report of Acorda Therapeutics.
2 Glial growth factor/neuregulin inhibits Schwann cell myelination and induces demyelination. J Cell Biol. 2001 Mar 19;152(6):1289-99.
3 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.